Covestor’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Covestor's AVIR Position: Q3 2026 in Review
Covestor increased its Atea Pharmaceuticals (AVIR) stake by 19% in Q3 2026, buying an estimated $36 and bringing the position to 43 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2341.
Covestor first reported a position in AVIR in Q4 2021 and has held it in 11 quarters since. The position peaked at $3K in Q1 2023. 89 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Covestor held 43 shares of Atea Pharmaceuticals worth $0 as of Q3 2026.
- Covestor bought 7 Atea Pharmaceuticals shares in Q3 2026, an estimated $36.
- Atea Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2341 holding.
- Covestor first reported a position in Atea Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
- Covestor's Atea Pharmaceuticals position peaked at $3K in Q1 2023.
- 89 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.